Preclinical studies have demonstrated that CGA exerts antitumor activity, possibly because of its ability to inhibit tyrosine kinases, matrix metalloproteinases, HIF-1α, and AKT, and more importantly to repolarize macrophages and enhance anti-cancer immunity in glioma6,8,9,14,15. This evidence concerns the gene AKT1 and cancer.